Back to search

Article

Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasites

2019-11-13

Abstract excerpt

<h4>Background: </h4> : Protozoan Leishmania parasites are responsible for a range of clinical infections that represent a substantial challenge for global health. Amphotericin B (AmB) is increasingly used to treat Leishmania infection, so understanding the potential for resistance to this drug is an important priority. Previously we described four independently-derived AmB-resistant L. mexicana lines that exhi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e8b97bb0-250d-5d65-a0ab-8555eb40b166
DOI
10.12688/wellcomeopenres.15452.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Untargeted metabolomics to understand the basis of phenotypic differences in amphotericin B-resistant Leishmania parasitesDOI 10.12688/wellcomeopenres.15452.1
Select a neighboring publication to make it the new centre.